Log In
BCIQ
Print this Print this
 

Recombinant hirudin

  Manage Alerts
Collapse Summary General Information
Company Chongqing Kerun Biopharmaceutical R&D Co. Ltd.
DescriptionDirect thrombin inhibitor
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentDiscovery
Standard Indication Cardiovascular (unspecified)
Indication DetailsTreat and prevent embolism
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today